Benjamine Liu is the CEO and Co-Founder of Formation Bio, a company revolutionizing the drug development process through the integration of technology and artificial intelligence. With a background in computational biology, Liu has leveraged his expertise to address inefficiencies in clinical trials, aiming to make treatments more accessible. Under his leadership, Formation Bio has made significant strides in the biotechnology and agriculture sectors.
Who is the CEO of Formation Bio?
Benjamine Liu, the CEO and Co-Founder of Formation Bio, has a rich background in computational biology. His career includes founding multiple organizations, such as ResearchWe, and serving as an advisor to Harvard Business School’s MS/MBA Program in Biotechnology. Liu's work has focused on integrating AI and technology into drug development, particularly in creating diagnostics and therapeutics for neurodegenerative diseases like Parkinson’s and Alzheimer’s.
His leadership at Formation Bio is characterized by a collaborative approach, bringing together experts from diverse fields to tackle the inefficiencies in clinical trials and expedite the drug discovery process.
Work History
Benjamine Liu's work history is extensive and diverse, reflecting his deep expertise in computational biology and related fields. Here is a list of the places he has worked previously:
- Formation Bio - CEO and Co-founder (2014 - Present)
- Harvard Business School - Advisor MS/MBA Biotech Program (2021 - Present)
- Translational Neuroscience and Dementia Research Group - Computational Biologist (2014 - 2016)
- Chen-Ploktin Lab, Department of Neurology - Computational Biologist (2013 - 2014)
- The John B. Pierce Laboratory, Inc. - Undergraduate Researcher (2009 - 2012)
- Teledyne Technologies, Division of Applied Computational Physics - Computational Scientist (2008)
- Department of Astronomy, UCLA - Research Assistant (2007 - 2008)
Education History
Benjamine Liu's educational journey is marked by prestigious institutions and a focus on computational biology. He earned his Doctor of Philosophy (D.Phil.) in Computational Biology and Psychiatry from the University of Oxford, where he studied from January 2013 to January 2016. Prior to that, Liu completed a Master of Philosophy (MPhil) in Computational Biology at the University of Cambridge's Department of Applied Mathematics and Theoretical Physics, from January 2012 to January 2013. His academic foundation was laid at Yale University, where he obtained an Intensive Bachelor of Science (BS) in Biology, graduating in 2012 after starting in January 2008. Additionally, Liu explored Comparative Health Policy, focusing on healthcare reforms in the US and UK, during a brief stint at Cambridge University in January 2010.
When did Benjamine Liu join Formation Bio?
Benjamine Liu co-founded Formation Bio in January 2014, marking the beginning of his tenure with the company. As the CEO and Co-Founder, Liu has been leading the organization since its inception. Over the past nine years, he has played a pivotal role in steering Formation Bio towards its mission of revolutionizing drug development through the integration of technology and artificial intelligence. His leadership has been instrumental in addressing inefficiencies in clinical trials and making treatments more accessible.